Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. Corcept Oncology is seeking an experienced and collaborative Associate Director, Market Intelligence & Decision Sciences to lead next best action (NBA) orchestration and advanced analytics across marketing, and market access domains. This individual will co-lead the design, deployment, and monitoring of next best action (NBA) orchestration and deliver high-impact analytics across marketing performance, digital engagement, and market access. This role will work in close partnership with Digital Marketing, Commercial Operations, Market Access, IT, and external partners. The ideal candidate brings strong experience in data-driven decisioning and orchestration platforms (e.g., Salesforce Marketing Cloud, CRM) and has operated in complex, matrixed commercial environments. While pharmaceutical experience is preferred, we are open to candidates from other industries with demonstrated expertise in decision sciences, personalization, and digital analytics.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
No Education Listed
Number of Employees
251-500 employees